Meiting Chen
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Lipid Membrane Structure and Behavior
- Cancer-related gene regulation
Papers in
-
- Circular RNAs in diseases 5
- Lipid Membrane Structure and Behavior 4
- Oncology 13
- HER2/EGFR in Cancer Research 5
- Viral-associated cancers and disorders 4
- Co-authors
- Haifeng Mao (2 shared papers)Shao-Peng Lin (2 shared papers)Youming Long (2 shared papers)Shan Ye (2 shared papers)Ji‐hang Yuan (1 shared paper)Ya-Wei Hsueh (3 shared papers)Jenifer Thewalt (2 shared papers)Mei Huang (1 shared paper)
- Journals
- BMC Cancer (4 papers)Biophysical Journal (3 papers)Annals of Hematology (3 papers)The Oncologist (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Meiting Chen
67 papers receiving 918 citations
Peers
Comparison fields: 5 of 113
- Cancer Research 205
- Molecular Biology 433
- Oncology 107
- Hepatology 28
- Immunology 66
Countries citing papers authored by Meiting Chen
This map shows the geographic impact of Meiting Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiting Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiting Chen more than expected).
Fields of papers citing papers by Meiting Chen
This network shows the impact of papers produced by Meiting Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiting Chen. The network helps show where Meiting Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiting Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 137 | |
| 2 | 2022 | 94 | |
| 3 | 2006 | 68 | |
| 4 | 2022 | 62 | |
| 5 | 2017 | 36 | |
| 6 | 2009 | 35 | |
| 7 | 2023 | 33 | |
| 8 | 2017 | 33 | |
| 9 | 2021 | 30 | |
| 10 | 2021 | 28 | |
| 11 | 2023 | 27 | |
| 12 | 2024 | 26 | |
| 13 | 2019 | 23 | |
| 14 | 2018 | 20 | |
| 15 | 2024 | 19 | |
| 16 | 2016 | 16 | |
| 17 | 2021 | 16 | |
| 18 | 2021 | 14 | |
| 19 | 2020 | 13 | |
| 20 | 2021 | 12 |
About Meiting Chen
Meiting Chen is a scholar working on Molecular Biology, Oncology, Surgery, Pathology and Forensic Medicine and Cancer Research, having authored 72 papers that have together received 927 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), HER2/EGFR in Cancer Research (5 papers), Circular RNAs in diseases (5 papers), Cancer-related molecular mechanisms research (4 papers), Viral-associated cancers and disorders (4 papers), Lipid Membrane Structure and Behavior (4 papers), Herpesvirus Infections and Treatments (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Cancer Research (205 citations), Molecular Biology (433 citations), Oncology (107 citations), Hepatology (28 citations) and Immunology (66 citations). Meiting Chen has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Haifeng Mao, Shao-Peng Lin, Youming Long, Shan Ye, Ji‐hang Yuan, Ya-Wei Hsueh, Jenifer Thewalt, Mei Huang, Qingsong Yang and Shuhan Sun. Their work appears in journals such as BMC Cancer, Biophysical Journal, Annals of Hematology, The Oncologist and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.